欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/1859/005
药品名称Belfor HCT 40 mg/10 mg/25 mg
活性成分
    • amlodipine besilate 10.0 mg
    • hydrochlorothiazide 25.0 mg
    • olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人Menarini International O.L. S.A. 1, Avenue de la Gare L-1611 Luxembourg
参考成员国 - 产品名称Netherlands (NL)
Belfor HCT
互认成员国 - 产品名称
    • Italy (IT)
    • Germany (DE)
      Vocado HCT 40 mg/10 mg/25 mg Filmtabletten
    • Belgium (BE)
    • Luxembourg (LU)
    • Ireland (IE)
    • Austria (AT)
      Amelior plus HCT 40 mg/10 mg/25 mg Filmtabletten
    • Spain (ES)
    • Portugal (PT)
    • Greece (GR)
    • Czechia (CZ)
      SINTONYN HCT 40 MG /10 MG/ 25 MG
    • Hungary (HU)
      DUACTAN HCT 40 mg/10 mg/25 mg filmtabletta
    • Poland (PL)
      Elestar HCT
    • Slovakia (SK)
      Folgan HCT 40 mg/10 mg/25 mg
    • Slovenia (SI)
    • Romania (RO)
      Inovum HCT 40 mg/10 mg/25 mg, comprimate filmate
    • Bulgaria (BG)
      Tespadan HCT
    • Cyprus (CY)
      ORIZAL PLUS 40mg/10mg/25mg FC TABS
    • Estonia (EE)
      SANORAL HCT
    • Latvia (LV)
    • Lithuania (LT)
      Sanoral HCT 40 mg/10 mg/25 mg plėvele dengtos tabletės
    • Malta (MT)
许可日期2010/12/02
最近更新日期2023/06/20
药物ATC编码
    • C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase